All Categories
Refine Search
Poloppin
Novel modulator of protein-protein interactions of the mitotic polo-like kinases, targeting mutant KRAS, acting synergistically with Crizotinib, an inhibitor of the c-MET receptor, against mutant KRAS-expressing cancer cells